Targeted News Service

Kirkland Advises Eli Lilly on $3.2B Morphic Acquisition
July 09, 2024

CHICAGO, Illinois, July 9 -- Kirkland and Ellis, a law firm, issued the following news release on July 8, 2024:

Kirkland & Ellis is representing Eli Lilly and Company (NYSE: LLY), which today announced a definitive agreement to acquire Morphic Holding, Inc. (NASDAQ: MORF), a biotechnology company that is developing oral integrin therapies for treatment of serious chronic diseases.

Lilly plans to commence a tender offer to acquire all outstanding shares of Morphic fo . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form